Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.5B | 3.3B | 3.3B | 3.2B |
Cost of revenue | 1.7B | 2.1B | 2.0B | 2.1B |
Gross profit | 841M | 1.3B | 1.2B | 1.1B |
Operating expense | ||||
Research & development | 489M | 523M | 492M | 348M |
Selling general and admin | 390M | 420M | 385M | 424M |
Other operating expenses | — | — | — | -58M |
Operating income | -38M | 310M | 351M | 520M |
Non operating interest income | ||||
Income | 48M | 72M | 75M | -60M |
Expense | — | 20M | 20M | 38M |
Other income expense | 62M | 56M | 26M | 126M |
Pretax income | 72M | 418M | 432M | 682M |
Tax provision | 13M | 82M | 71M | 67M |
Net income | 59M | 336M | 361M | 615M |
Basic EPS | 0.1 | 0.4 | 0.4 | 0.4 |
Diluted EPS | 0.1 | 0.4 | 0.4 | 0.4 |
Basic average shares | 1.1B | 1.0B | 1.0B | 1.0B |
Diluted average shares | 1.1B | 1.1B | 1.1B | 1.1B |
EBITDA | 373M | 897M | 746M | 1.1B |
Net income from continuing op. | — | 336M | 100M | 615M |
Minority interests | -3M | 5M | -10M | -2M |
Preferred stock dividends | — | — | — | — |